Neurobiological Mechanisms of Aging and Stress on Prospective Navigation

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Sep 1, 2026 → Dec 25, 2026
See other at-risk trials from Georgia Institute of Technology

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary and study completion pushed from Sep 1, 2026 to Dec 25, 2026
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints: details revised at 2 of 2 entries
  2. Minor Primary and study completion dates: Mar 31, 2026 to Sep 1, 2026v15
  3. Minor Primary and study completion dates: Dec 15, 2025 to Mar 31, 2026v14
  4. Notable Primary and study completion dates: Jun 1, 2025 to Dec 15, 2025
    • Site contact updated
    v13
  5. Notable Primary and study completion dates: Oct 31, 2024 to Jun 1, 2025
    • Site contact updated
    v12
Show 10 earlier versionsHide 10 earlier versions
  1. Notable Primary and study completion dates: Mar 31, 2024 to Oct 31, 2024v11
  2. Minor Collaborators expanded, about 5 wordsv10
  3. Notable Primary and study completion dates: Mar 31, 2023 to Mar 31, 2024v9
  4. Notable Primary and study completion dates: Mar 31, 2022 to Mar 31, 2023v8
  5. Notable Primary and study completion dates: Mar 31, 2021 to Mar 31, 2022v7
  6. Notable Primary completion date: Oct 1, 2020 to Mar 31, 2021
    • Start date: Apr 15, 2019 to Sep 24, 2019
    v6
  7. Minor Site contact updatedv5
  8. Minor Eligibility criteria shortened, about 5 wordsv4
  9. Minor Secondary endpoints: 1 to 2
    • Study description expanded, about 14 words
    v3
  10. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2019 to Apr 15, 2019
    • Site details revised
    v2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Two hallmarks of both healthy aging and age-related disease are 1) memory and navigational deficits, particularly in orienting towards goal locations and planning how to navigate to them, and 2) increased susceptibility to stress and altered regulation of the stress response. However, there are marked individual differences in these age-related changes. The investigators' proposal will help characterize factors that contribute to this variability. Participants will be pseudorandomly assigned to stress-manipulated or control groups. The investigators will give both groups a novel immersive navigation task, validated by the PI in healthy young adults. This paradigm gives participants the opportunity to either (a) flexibly draw on spatial memory in order to plan efficient routes to goal locations, or (b) fall back on inefficient, but cognitively less-demanding, stimulus-response associations (i.e., habits). Using neuroimaging and behavioral measures, the investigators' protocol will test whether experimentally-induced stress leads individuals to bring fewer details about future locations to mind when route planning, and whether such restricted prospective thought ultimately biases participants towards relatively inflexible, habitual actions.
Trial Details
NCT Number NCT03896529
Lead Sponsor Georgia Institute of Technology
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)
Aging, Anxiety, Memory Impairment
Related terms Anxiety Disorders, Memory Disorders
Enrollment 85 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov